GABA dysfunction in the pathophysiology of tardive dyskinesia.

C. A. Tamminga, G. K. Thaker, T. N. Chase

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Pharmacologic treatments which diminish central dopaminergic transmission improve symptoms of tardive dyskinesia (TD). These clinical data, supported by results from animal model studies, have provided a basis for the dopamine (DA) receptor hypersensitivity hypothesis of TD. Since its initial formulation, however, knowledge of the multiple effects of prolonged neuroleptic administration in mammalian CNS has greatly expanded. Clinical and animal model studies carried out independently now both suggest that GABA-mediated neuronal tracts of the basal ganglia are important, perhaps pivotal, in TD. Thus, we would extend the DA hypothesis of TD to include the idea that neuroleptic-induced DA receptor hypersensitivity in striatum results in GABA system hypofunction in striatal projection areas in those individuals who develop TD.

Original languageEnglish (US)
Pages (from-to)122-127
Number of pages6
JournalPsychopharmacology. Supplementum
Volume2
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'GABA dysfunction in the pathophysiology of tardive dyskinesia.'. Together they form a unique fingerprint.

  • Cite this